Month: April 2015
Physical therapy as good as surgery and less risky for one type of lower back pain
Germanwings Flight 9525 shows the limits of predicting human violence
An apple a day may not keep the doctor away, but it’s a healthy choice anyway
Test May Show Return of Lymphoma Sooner
Measuring a type of DNA found in tumors can help detect whether the most common type of lymphoma has returned after treatment, a study finds. The study focused on diffuse large B-cell lymphoma, known as DLBCL. It often can be cured. But people need to come back for CT or PET scans to look for a return of the cancer. The new study looked at another possible test. The study enrolled 126 people with DLBCL. They had been treated with chemotherapy between 1993 and 2013. Researchers took blood samples before and after treatment and during follow-up. They tested the samples for a type of DNA comes from the tumor. People also received follow-up CT scans. In all, 107 people had all signs of their cancer disappear with treatment. Those who had detectable tumor DNA in their blood during follow-up were 200 times more likely to have a return of the cancer than those with no detectable levels.
Thyroid Disease: Understanding hypothyroidism and hyperthyroidism
Healthy Feet: Preventing and treating common foot problems
Update From the Medical Journals March 2015
Everywhere, hospitals are merging — but why should you care?
Blood-Pressure Advice Targets Heart Patients
Three expert groups have released blood-pressure treatment guidelines for people who already have heart problems. The guidelines focus on people with coronary artery disease. This is a narrowing of arteries to the heart because of plaque buildup. The guidelines say most people in this group should aim for a blood-pressure level of less than 140/90 millimeters of mercury (mmHg). The goal is 130/80 mmHg for those who already have had a heart attack, stroke or mini-stroke. This lower goal also applies to those who have had a narrowing of leg arteries or an abdominal aortic aneurysm. The guidelines come from a committee of experts. They represent many groups involved with the treatment of heart disease. In an interview with HealthDay News, the committee chairman said the guidelines are intended to be flexible.